(Q35687664)

9 August 2017

1 reference

title

Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease (English)

1 reference

gastroesophageal reflux disease

9 August 2017

main subject

0 references

author name string

Kwong Ming Fock

1

1 reference

9 August 2017

Nick Talley

2

1 reference

9 August 2017

Richard Hunt

3

1 reference

9 August 2017

Ronnie Fass

4

1 reference

9 August 2017

Sanjay Nandurkar

5

1 reference

9 August 2017

Shiu-Kum Lam

6

1 reference

9 August 2017

Khean Lee Goh

7

1 reference

9 August 2017

Jose Sollano

8

1 reference

9 August 2017

publication date

1 April 2004

1 reference

Journal of Gastroenterology and Hepatology

9 August 2017

published in

1 reference

9 August 2017

volume

19

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

357-367

1 reference

Gastro-oesophageal reflux disease in Asia

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Prevalence of endoscopic reflux esophagitis among Koreans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Role of hiatus hernia and gastric mucosal atrophy in the development of reflux esophagitis in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Prevalence, clinical spectrum and health care utilization of gastro-oesophageal reflux disease in a Chinese population: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Empirical treatment based on "typical" reflux symptoms is inappropriate in a population with a high prevalence of Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Esophageal histology does not provide additional useful information over clinical assessment in identifying reflux patients presenting for esophagogastroduodenoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Diagnosis of symptomatic gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Symptomatic response to lansoprazole predicts abnormal acid reflux in endoscopy-negative patients with non-cardiac chest pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Corpus gastritis in patients with endoscopic diagnosis of reflux oesophagitis and Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

The effect of Helicobacter pylori eradication on gastro-oesophageal reflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Effectiveness and safety of nizatidine, 75 mg, for the relief of episodic heartburn

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Nonprescription doses of ranitidine are effective in the relief of episodic heartburn

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

On-demand treatment of gastro-oesophageal reflux symptoms: a comparison of ranitidine 75 mg with cimetidine 200 mg or placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Meta-analysis: comparing the efficacy of proton pump inhibitors in short-term use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Famotidine relieves symptoms of gastroesophageal reflux disease and heals erosions and ulcerations. Results of a multicenter, placebo-controlled, dose-ranging study. USA Merck Gastroesophageal Reflux Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

High- versus standard-dose ranitidine for control of heartburn in poorly responsive acid reflux disease: a prospective, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis--a placebo-controlled randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Endocinch therapy for gastro-oesophageal reflux disease: a one year prospective follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Endoscopic, deep mural implantation of Enteryx for the treatment of GERD: 6-month follow-up of a multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Endoluminal therapies for gastro-oesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

High dose proton pump inhibitor response as an initial strategy for a clinical diagnosis of gastro-oesophageal reflux disease (GERD). Swedish multi-centre group in primary health care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Long-term prospective follow-up of endoscopic oesophagitis in southern Chinese--prevalence and spectrum of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Clinical characteristics of Japanese reflux esophagitis patients as determined by Los Angeles classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Erosive esophagitis and Barrett's esophagus in Taiwan: a higher frequency than expected

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Non-erosive reflux disease (NERD)--acid reflux and symptom patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

An 18-year follow-up study of chronic gastritis and Helicobacter pylori association of CagA positivity with development of atrophy and activity of gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Risk factors associated with symptoms of gastroesophageal reflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Gastroesophageal reflux induced by white wine: the role of acid clearance and "rereflux"

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Clinical effectiveness of laparoscopic fundoplication in a U.S. community

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Transoral, flexible endoscopic suturing for treatment of GERD: a multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

Endoscopic implantation of Plexiglas (PMMA) microspheres for the treatment of GERD

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03419.X

10.1111/J.1440-1746.2004.03419.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference